ENTRY       D11666                      Drug
NAME        Nipocalimab (USAN)
FORMULA     C6266H9722N1670O1992S46
EXACT_MASS  141707.7937
MOL_WEIGHT  141795.2227
SEQUENCE    (Heavy chain)
            EVQLLESGGG LVQPGGSLRL SCAASGFTFS TYAMGWVRQA PGKGLEWVSS IGASGSQTRY
            ADSVKGRFTI SRDNSKNTLY LQMNSLRAED TAVYYCARLA IGDSYWGQGT MVTVSSASTK
            GPSVFPLAPS SKSTSGGTAA LGCLVKDYFP EPVTVSWNSG ALTSGVHTFP AVLQSSGLYS
            LSSVVTVPSS SLGTQTYICN VNHKPSNTKV DKKVEPKSCD KTHTCPPCPA PELLGGPSVF
            LFPPKPKDTL MISRTPEVTC VVVDVSHEDP EVKFNWYVDG VEVHNAKTKP REEQYASTYR
            VVSVLTVLHQ DWLNGKEYKC KVSNKALPAP IEKTISKAKG QPREPQVYTL PPSREEMTKN
            QVSLTCLVKG FYPSDIAVEW ESNGQPENNY KTTPPVLDSD GSFFLYSKLT VDKSRWQQGN
            VFSCSVMHEA LHNHYTQKSL SLSPG
            (Light chain)
            QSALTQPASV SGSPGQSITI SCTGTGSDVG SYNLVSWYQQ HPGKAPKLMI YGDSERPSGV
            SNRFSGSKSG NTASLTISGL QAEDEADYYC SSYAGSGIYV FGTGTKVTVL GQPKAAPSVT
            LFPPSSEELQ ANKATLVCLI SDFYPGAVTV AWKADSSPVK AGVETTTPSK QSNNKYAASS
            YLSLTPEQWK SHKSYSCQVT HEGSTVEKTV APTECS
            (disulfide bridge: H22-H96, H143-H199, H219-L215, H225-H'225, H228-H'228, H260-H320, H366-H424, H'22-H'96, H'143-H'199, H'219-L'215, H'260-H'320, H'366-H'424, L22-L90, L138-L197, L'22-L'90, L'138-L'197)
  TYPE      Peptide
EFFICACY    Autoimmune disease treatment, Anti-Fc receptor antibody
  TYPE      Monoclonal antibody
COMMENT     Treatment of diseases mediated by pathogenic IgG autoantibodies and alloantibodies
TARGET      FCGRT [HSA:2217] [KO:K24019]
BRITE       Target-based classification of drugs [BR:br08310]
             Not elsewhere classified
              Organismal systems
               Immune system
                FCGRT
                 D11666  Nipocalimab (USAN)
DBLINKS     CAS: 2211985-36-1
            PubChem: 405226533
///
